News Sentiment

LXEO sentiment intelligence

Lexeo Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.82 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+2.8% over one week, +10.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 2.8% Price confirming higher
Trend fit Trend inactive 10.3% over four weeks
Fair value -44.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 46
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
Market source 7
GlobeNewswire 6
TradingView 4
Simply Wall Street 3
Investing.com Canada 3
simplywall.st 3
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 19
Analyst action 3
Regulatory and legal 2
Deals and strategy 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
Moomoo Direct company coverage

Lexeo Therapeutics Is Maintained at Overweight by JP Morgan

JP Morgan has reiterated its "Overweight" rating on Lexeo Therapeutics. The article states that this is a maintenance of a previous rating. No further details about the reasons behind the rating or the company's performance are provided.

Tone
Positive 68/100
Event
Analyst action
Published
26 Jun 2026 01:39
Source
Moomoo